Boram Han

1.2k total citations
56 papers, 877 citations indexed

About

Boram Han is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, Boram Han has authored 56 papers receiving a total of 877 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Oncology, 19 papers in Pulmonary and Respiratory Medicine and 11 papers in Molecular Biology. Recurrent topics in Boram Han's work include Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Boram Han is often cited by papers focused on Colorectal Cancer Treatments and Studies (9 papers), Cancer Genomics and Diagnostics (8 papers) and Pancreatic and Hepatic Oncology Research (7 papers). Boram Han collaborates with scholars based in South Korea, United States and Nigeria. Boram Han's co-authors include Jung Han Kim, Hyeong Su Kim, Dae Young Zang, Joon Oh Park, Jeeyun Lee, Won Ki Kang, Dae Ro Choi, Won Seog Kim, Seok Jin Kim and Taekyu Lim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Boram Han

52 papers receiving 862 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Boram Han South Korea 17 342 334 241 160 152 56 877
Seong Yoon Yi South Korea 22 466 1.4× 487 1.5× 251 1.0× 301 1.9× 128 0.8× 70 1.2k
Tao Jin China 18 289 0.8× 288 0.9× 203 0.8× 271 1.7× 83 0.5× 73 1.0k
Deniz Tural Türkiye 17 377 1.1× 478 1.4× 116 0.5× 217 1.4× 143 0.9× 121 938
Michael Pohl Germany 18 267 0.8× 290 0.9× 161 0.7× 163 1.0× 109 0.7× 48 780
Hye Sung Won South Korea 22 289 0.8× 519 1.6× 376 1.6× 227 1.4× 284 1.9× 88 1.3k
Renata D’Alpino Peixoto Brazil 17 320 0.9× 569 1.7× 119 0.5× 295 1.8× 164 1.1× 95 964
Suresh C. Sharma India 20 196 0.6× 175 0.5× 155 0.6× 419 2.6× 116 0.8× 70 1.2k
Naoe Goto Japan 22 190 0.6× 397 1.2× 199 0.8× 203 1.3× 55 0.4× 66 1.2k
Rei Suzuki Japan 19 322 0.9× 505 1.5× 248 1.0× 476 3.0× 165 1.1× 134 1.1k
Doğan Uncu Türkiye 15 261 0.8× 348 1.0× 80 0.3× 161 1.0× 65 0.4× 96 704

Countries citing papers authored by Boram Han

Since Specialization
Citations

This map shows the geographic impact of Boram Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boram Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boram Han more than expected).

Fields of papers citing papers by Boram Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Boram Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boram Han. The network helps show where Boram Han may publish in the future.

Co-authorship network of co-authors of Boram Han

This figure shows the co-authorship network connecting the top 25 collaborators of Boram Han. A scholar is included among the top collaborators of Boram Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Boram Han. Boram Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Jwa-Kyung, Han Na Jung, Bum Jun Kim, et al.. (2025). Burden of End-Stage Kidney Disease by Type 2 Diabetes Mellitus Status in South Korea: A Nationwide Epidemiologic Study. Diabetes & Metabolism Journal. 49(3). 498–506. 1 indexed citations
2.
Jung, Han Na, Ji Hye Huh, Eun Youn Roh, et al.. (2025). Risk of pancreatic cancer according to glycemic status in nonalcoholic fatty liver disease: a nationwide cohort study. Scientific Reports. 15(1). 23308–23308.
3.
Roh, Juhye, Yonggeun Cho, Boram Han, & Young Lee. (2022). The First Case of Adult Granular Acute Lymphoblastic Leukemia with DNMT3A Mutation and Monosomy 7.. PubMed. 52(5). 846–849.
4.
Atsawarungruangkit, Amporn, et al.. (2020). Evolving global and national criteria for identifying a suspected case of COVID-19. Journal of International Medical Research. 48(8). 1220738495–1220738495. 7 indexed citations
5.
Yoo, Kwai Han, Jinhyun Cho, Boram Han, et al.. (2020). Outcomes of decitabine treatment for newly diagnosed acute myeloid leukemia in older adults. PLoS ONE. 15(8). e0235503–e0235503. 2 indexed citations
6.
Yoo, Changhoon, Boram Han, Hyeong Su Kim, et al.. (2018). Multicenter Phase II Study of Oxaliplatin, Irinotecan, and S-1 as First-line Treatment for Patients with Recurrent or Metastatic Biliary Tract Cancer. Cancer Research and Treatment. 50(4). 1324–1330. 21 indexed citations
7.
Kim, Jung Han, Hyeong Su Kim, Bum Jun Kim, et al.. (2018). Prognostic Impact of TTF-1 Expression in Non-Squamous Non-Small-Cell Lung Cancer: A Meta-Analysis. Journal of Cancer. 9(22). 4279–4286. 35 indexed citations
8.
Choi, Dae Ro, Sang Nam Yoon, Hyeong Su Kim, et al.. (2015). A phase II study of capecitabine and oral leucovorin as a third-line chemotherapy in patients with metastatic colorectal cancer. Cancer Chemotherapy and Pharmacology. 75(3). 639–643. 2 indexed citations
9.
Jung, Hyunchul, Woo Kyun Kim, Kyoung‐Jin Oh, et al.. (2015). Intracellular annexin A2 regulates NF-κB signaling by binding to the p50 subunit: implications for gemcitabine resistance in pancreatic cancer. Cell Death and Disease. 6(1). e1606–e1606. 69 indexed citations
10.
Jung, Joo Young, Ho Young Kim, Boram Han, et al.. (2014). The Positive Effects of One-Hour Intravenous Administration of Bortezomib on Peripheral Neuropathy in Multiple Myeloma Patients. BioMed Research International. 2014. 1–6. 3 indexed citations
11.
Kwon, Mi Jung, Jang Yong Jeon, Hye‐Rim Park, et al.. (2014). Low Frequency of KRAS Mutation in Pancreatic Ductal Adenocarcinomas in Korean Patients and Its Prognostic Value. Pancreas. 44(3). 484–492. 21 indexed citations
12.
Ahn, Hee Kyung, Kyeongman Jeon, Hongseok Yoo, et al.. (2013). Successful Treatment with Crizotinib in Mechanically Ventilated Patients with ALK Positive Non–Small-Cell Lung Cancer. Journal of Thoracic Oncology. 8(2). 250–253. 31 indexed citations
13.
Han, Boram, Choong Kee Park, Jong Hyeok Kim, et al.. (2013). Phase II trial of gemcitabine and S-1 for patients with advanced pancreatic cancer. Cancer Chemotherapy and Pharmacology. 72(4). 845–852. 12 indexed citations
14.
Han, Boram, Jong‐Mu Sun, Jin Seok Ahn, Keunchil Park, & Myung‐Ju Ahn. (2013). Clinical outcomes of atypical carcinoid tumors of the lung and thymus: 7-year experience of a rare malignancy at single institute. Medical Oncology. 30(1). 479–479. 12 indexed citations
15.
Ahn, Hee Kyung, Boram Han, Su Jin Lee, et al.. (2012). ALK inhibitor crizotinib combined with intrathecal methotrexate treatment for non-small cell lung cancer with leptomeningeal carcinomatosis. Lung Cancer. 76(2). 253–254. 26 indexed citations
16.
Lee, Soo Hyun, Myung Hee Chang, Kyung Kee Baek, et al.. (2011). High-Dose Ifosfamide as Second- or Third-Line Chemotherapy in Refractory Bone and Soft Tissue Sarcoma Patients. Oncology. 80(3-4). 257–261. 26 indexed citations
17.
Lim, Taekyu, Seok Jin Kim, Kihyun Kım, et al.. (2011). Primary CNS lymphoma other than DLBCL: a descriptive analysis of clinical features and treatment outcomes. Annals of Hematology. 90(12). 1391–1398. 45 indexed citations
18.
Lim, Taekyu, Jeeyun Lee, Ha Yeon Lee, et al.. (2011). Phase I trial of capecitabine plus everolimus (RAD001) in patients with previously treated metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 68(1). 255–262. 30 indexed citations
19.
Kim, Jung A, Jeeyun Lee, Boram Han, et al.. (2010). Docetaxel/cisplatin followed by FOLFIRI versus the reverse sequence in metastatic gastric cancer. Cancer Chemotherapy and Pharmacology. 68(1). 177–184. 10 indexed citations
20.
Kim, Young‐Hwan, Boram Han, William B. Titlow, et al.. (2009). Utility of RNAi-mediated prnp gene silencing in neuroblastoma cells permanently infected by prions: Potentials and limitations. Antiviral Research. 84(2). 185–193. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seong Yoon Yi Breakdown of academic impact, for papers by Tao Jin Breakdown of academic impact, for papers by Deniz Tural Breakdown of academic impact, for papers by Michael Pohl Breakdown of academic impact, for papers by Hye Sung Won Breakdown of academic impact, for papers by Renata D’Alpino Peixoto Breakdown of academic impact, for papers by Suresh C. Sharma Breakdown of academic impact, for papers by Naoe Goto Breakdown of academic impact, for papers by Rei Suzuki Breakdown of academic impact, for papers by Doğan Uncu
Rankless by CCL
2026